期刊文献+

我国七个血清酶检验项目检测质量分析 被引量:3

Quality assessment of seven kinds of sero-enzyme tests in China
原文传递
导出
摘要 目的评价中国丙氨酸转氨酶( ALT)、天冬氨酸转氨酶( AST)、γ-谷氨酰基转移酶(GGT)、乳酸脱氢酶(LDH)、肌酸激酶(CK)、α-淀粉酶(AMY)、碱性磷酸酶(ALP)等7项血清酶各检测系统的质量情况。方法现况调查。卫生部临检中心2013年生化EQA共15个批号样本及酶学正确度验证共3个批号样本的ALT、AST、GGT、LDH、CK、AMY、ALP回报数据,筛选出信息填报完整的1450家及165家参评实验室作为调查对象。将实验室检测系统分为进口配套系统( AI)、国产配套系统( AH)、进口试剂及相应配套校准品系统( BI)、国产试剂及相应配套校准品系统( BH)、除A、B类外采用进口校准品的非配套系统( CI)与采用国产校准品的非配套系统( CH)。计算7项血清酶的常规室间质评及正确度验证总误差、偏移、室内变异等参数,以生物学变异导出的最佳及适当指标作为评价标准,计算各检测系统内符合不同评价标准的实验室比例,以符合率>85%为判定标准。结果6类常规检测系统中AI与CI类比例总和超过70%,CH类约为15%,其余系统不足10%。7项酶的正确度验证总误差均值范围6.2%~27.8%,常规室间质评总误差均值范围4.0%~7.0%,常规检测偏移绝对值均值范围4.2%~25.1%,室内变异均值范围3.6%~4.6%。分别以正确度验证总误差符合率、偏移符合率、室内变异符合率及常规室间质评总误差符合率评价各检测系统的准确度及其偏移与实验室室内不精密度,了解各检测系统间的可比性,结果为除ALP外其余6项酶的各检测系统具有可比性、除AMY、ALP 及系统AI 的GGT、LDH外其余各酶相应检测系统的准确度、除LDH、AMY、ALP及系统AI、CH的AST外其余各酶的室内不精密度均达适当标准,所有系统7项血清酶检测结果偏移未达适当标准。结论我国7项血清酶常规检测分析质量可基本满足临床需求。(中华检验医学杂志,2015,38:313-317) Objective To evaluate the analytical quality of different analytical systems in measuring seven kinds of sero-enzymes consisting of Alanine Aminotransferase(ALT), Aspartate Aminotransferase (AST),γ-Glutamyltransferase(GGT), Lactate Dehydrogenase(LDH), Creatine Kinase(CK), α-Amylase (AMY) and Alkaline Phosphatase(ALP).Methods Data from 2013 routine chemistry external quality assessment (EQA) and Enzymes Trueness Verification(ETV) were collected.1 450 and 165 participating laboratories were selected respectively for investigation.Analytical systems of participating laboratories were classified into 6 kinds,i.e.imported matching system(AI), domestic matching system(AH), systems consisting of imported reagents and corresponding calibrators(BI), systems consisting of domestic reagents and corresponding calibrators ( BH ) , unmatched systems using imported calibrators ( CI ) and unmatched systems using domestic calibrators ( CH ) .Total error, bias and coefficient of variation within laboratories ( CVI) were calculated from the data of 2013EQA and ETV The proportion of laboratories meeting the desirable and the optimal criteria derived from biology variation were analyzedby EXCEL2010 with coincidence rate (CR) above 85% as evaluation criterion.Results The AI and CI occupied more than 70%among six systems, CH occupied approximate 15% and the other systems were less than 10%.The 〈br〉 range of the average of ETV′s total errors , EQA′s total errors, absolute value of bias and CVI of seven kinds of sero-enzymes were 6.2%-27.8%, 4.0%-7.0%, 4.2%-25.1% and 3.6%-4.6% respectively. Accuracy, bias and within-laboratory imprecision were judged by CR of ETV′s total errors, ETV′s bias, CVI and EQA′s total errors respectively and comparability between different systems was evaluated.It turned out that the results of analytical systems of enzymes except ALP were comparable, the accuracy of systems of enzymes except AMY, ALP and GGT, LDH of AI, the within-laboratory imprecision of enzymes except LDH, AMY, ALP and AST of AI, CH could meet the desirable criteria.The bias of all systems of seven kinds of sero-enzymes were undesirable.Conclusions The analytical quality of routine testing of seven kinds of sero-enzymes could fulfill the clinical requirement generally in China.
机构地区 北京医院
出处 《中华检验医学杂志》 CAS CSCD 北大核心 2015年第5期313-317,共5页 Chinese Journal of Laboratory Medicine
基金 国家高技术研究发展计划资助项目(2011AA02A102、2011AA02A116)
关键词 诊断试验 常规 实验室能力验证 质量保证 卫生保健 Diagnosis tests,outine Laboratory proficiency testing Quality assurance,health care
  • 相关文献

参考文献9

  • 1中华人民共和国国家质量监督检验检疫总局,中国国家标准化管理委员会.WS/T352-2011,丙氨酸氨基转移酶催化活性浓度测定(无磷酸吡哆醛)参考方法[s].中华人民共和国卫生部,2011.
  • 2中华人民共和国国家质量监督检验检疫总局,中国国家标准化管理委员会.WS/T353-2011,天门冬氨酸氨基转移酶催化活性浓度测定(无磷酸吡哆醛)参考方法[S].中华人民共和国卫生部,2011.
  • 3Ric6s C, Alvarez V, Cava F, et al. Current databases on biologic variation : pros, cons and progress [ J ]. Scand J Clin Lab Invest, 1999,59(7) :491-500.
  • 4中华人民共和国卫生部.临床生物化学检验常规项目分析质量指标[S].WS/T403-2012,中华人民共和国卫生部,2012.
  • 5何法霖,白玉,王薇,钟堃,王治国.由生物学变异确定的质量规范在常规化学室间质评和室内质控中的应用[J].中华检验医学杂志,2012,35(6):531-537. 被引量:30
  • 6Panteghini M, Ceriotti F, Schumann G, et al. Establishing a reference system in clinical enzymology[ J]. Clin Chem Lab Med, 2001,39(9) :795-800.
  • 7Rosalki SB, Bayoumi RA. Activation by pyridoxal 5-phosphate of aspartate transaminase in serum of patients with heart and liver disease[J]. Clin Chim Acta,1975,59(3) :357-360.
  • 8Mastroianni A, Longoni PD, Franzini C, et al. Importance of pyridoxal-5'-Phosphate addition to the assay medium for the measurement of catalytic concentrations of plasma aspartate and alanine aminotransferases in patients undergoing antineoplastic chemotherapy [ J ]. Eur J C1 in Chem Clin Biochem, 1996,34 ( 6 ) : 507-510.
  • 9Mauro Panteghini. Traceability, reference systems and result comparability[ J]. Clin Biochem Rev ,2007,28 ( 8 ) :97-104.

二级参考文献12

共引文献33

同被引文献8

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部